English

GreenLight Biosciences Holdings, PBC

EDGAR

ENVI Filing (3) · filed 2023-07-27

58 filing records in this dataset, filed from 2020-12-21 to 2023-07-27. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Insider filings have not been processed for this company yet.

See all insider transactions

Institutional holders (Form 13F) are not yet shown here.

Latest quarter

Revenue

3.82 million USD

2023 Q1 · USD

Exact inputs and evidence

Revenue: 3820000 USD Source

Operating margin

-740.63%

2023 Q1 · %

Exact inputs and evidence

Operating Income: -28292000 USD Source
Revenue: 3820000 USD Source

Operating cash flow

-31.1 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -31100000 USD Source

Free cash flow

-32.7 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -31100000 USD Source
Capital Expenditure: 1608000 USD Source

Cash and cash equivalents: 32.4 million USD 2023-03-31 Source
Exact value

32400000 USD
Long-term debt including current maturities: 34.4 million USD 2021-12-31
Exact inputs and evidence

34386000 USD

Long-term debt including current maturities: 34386000 USD Source
Shares outstanding: 152 million shares 2023-03-31 Source
Exact value

151681314 shares

Reported share-count change

23.34% · 28.7 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

122980505 shares · 2022-03-31· Source
151681314 shares · 2023-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

10.3 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Revenue: 1768000 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 1732000 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 6780000 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 3757000 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 3820000 USD · 2023-01-01 – 2023-03-31 Source

Net income

-157 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Net income: -51926000 USD · 2022-04-01 – 2022-06-30 Source
Net income: -38158000 USD · 2022-07-01 – 2022-09-30 Source
Net income: -167055000 USD · 2022-01-01 – 2022-12-31 Source
Net income: -128291000 USD · 2022-01-01 – 2022-09-30 Source
Net income: -28469000 USD · 2023-01-01 – 2023-03-31 Source

Capital expenditure

27.9 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Capital expenditure: 12870000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 287000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 22944000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 12870000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 26547000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 22944000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 1608000 USD · 2023-01-01 – 2023-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-07-27.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2022-12-31
Operating income: 4 of 11 periods available· newest 2022-12-31
Net income: 4 of 11 periods available· newest 2022-12-31
Operating cash flow: 4 of 11 periods available· newest 2022-12-31
Capital expenditure: 4 of 11 periods available· newest 2022-12-31
Total assets: 4 of 11 periods available· newest 2022-12-31
Total liabilities: 4 of 11 periods available· newest 2022-12-31
Current assets: 4 of 11 periods available· newest 2022-12-31
Current liabilities: 4 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2022-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2021-12-31
Shares outstanding: 4 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+325.1%

Prior period

USD 1.6 million

2021-01-01 – 2021-12-31
Current period

USD 6.78 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

6780000 − 1595000 = 5185000 USD

1595000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
6780000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GreenLight Biosciences Holdings, PBC · 2022-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Year-over-year change in Revenue: 5185000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 6780000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3104527 Filing: 000095017023010351 Input fundies:Revenue: 1595000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3106421 Filing: 000095017023010351
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 54.75 million

Prior period

−USD 112.31 million

2021-01-01 – 2021-12-31
Current period

−USD 167.06 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-167055000 − -112310000 = -54745000 USD

-112310000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-167055000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GreenLight Biosciences Holdings, PBC · 2022-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Year-over-year change in Net income: -54745000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -167055000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#4903951 Filing: 000095017023010351 Input fundies:NetIncome: -112310000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#4906384 Filing: 000095017023010351
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 44.9 million

Prior period

−USD 91.8 million

2021-01-01 – 2021-12-31
Current period

−USD 136.7 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-136700000 − -91800000 = -44900000 USD

-91800000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-136700000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GreenLight Biosciences Holdings, PBC · 2022-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Year-over-year change in Operating cash flow: -44900000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -136700000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3718989 Filing: 000095017023010351 Input fundies:OperatingCashFlow: -91800000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3719733 Filing: 000095017023010351
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+75.3%

Prior period

USD 15.15 million

2021-01-01 – 2021-12-31
Current period

USD 26.55 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

26547000 − 15148000 = 11399000 USD

15148000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
26547000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GreenLight Biosciences Holdings, PBC · 2022-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Year-over-year change in Capital expenditure: 11399000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 26547000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3516397 Filing: 000095017023010351 Input fundies:CapitalExpenditure: 15148000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3518751 Filing: 000095017023010351
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 6.78 million 100% of revenue
Operating costs Derived USD 170.7 million 2,518% of revenue
Operating income −USD 163.92 million −2,418% of revenue
Tax, interest and other Derived USD 3.14 million 46% of revenue
Net income −USD 167.06 million −2,464% of revenue

Cash

Operating cash flow −USD 136.7 million −2,016% of revenue
Capital expenditure USD 26.55 million 392% of revenue
Free cash flow Derived −USD 163.25 million −2,408% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Operating loss: operating costs were 1,073% of revenue.
2020 Operating loss: operating costs were 3,093% of revenue.
2021 Operating loss: operating costs were 6,906% of revenue.
2022 Operating loss: operating costs were 2,518% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	3001000	32203000 Derived	-29202000	-553000 Derived	-28649000	-27532000 Derived	Source 2019-01-01 – 2019-12-31: 3001000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -29202000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -28649000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -25636000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1896000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	1747000	54031000 Derived	-52284000	967000 Derived	-53251000	-56647000 Derived	Source 2020-01-01 – 2020-12-31: 1747000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -52284000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -53251000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -46600000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 10047000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	1595000	110153000 Derived	-108558000	3752000 Derived	-112310000	-106948000 Derived	Source 2021-01-01 – 2021-12-31: 1595000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -108558000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -112310000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -91800000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 15148000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	6780000	170699000 Derived	-163919000	3136000 Derived	-167055000	-163247000 Derived	Source 2022-01-01 – 2022-12-31: 6780000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -163919000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -167055000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -136700000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 26547000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 6.8M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Revenue	3001000	Revenue: 3001000 Open source
20202020-12-31	Revenue	1747000	Revenue: 1747000 Open source
20212021-12-31	Revenue	1595000	Revenue: 1595000 Open source
20222022-12-31	Revenue	6780000	Revenue: 6780000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

325.1% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 3001000 Open source
20202020-12-31	Year over year	-41.8%	Revenue: 1747000 Open source Revenue: 3001000 Open source
20212021-12-31	Year over year	-8.7%	Revenue: 1595000 Open source Revenue: 1747000 Open source
20222022-12-31	Year over year	325.1%	Revenue: 6780000 Open source Revenue: 1595000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2,417.7% 2022

Net margin -2,463.9% 2022

Free cash flow margin -2,407.8% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	-973.1%	Operating Income: -29202000 Open source Revenue: 3001000 Open source
20202020-12-31	Operating margin	-2,992.8%	Operating Income: -52284000 Open source Revenue: 1747000 Open source
20212021-12-31	Operating margin	-6,806.1%	Operating Income: -108558000 Open source Revenue: 1595000 Open source
20222022-12-31	Operating margin	-2,417.7%	Operating Income: -163919000 Open source Revenue: 6780000 Open source
20192019-12-31	Net margin	-954.6%	Net Income: -28649000 Open source Revenue: 3001000 Open source
20202020-12-31	Net margin	-3,048.1%	Net Income: -53251000 Open source Revenue: 1747000 Open source
20212021-12-31	Net margin	-7,041.4%	Net Income: -112310000 Open source Revenue: 1595000 Open source
20222022-12-31	Net margin	-2,463.9%	Net Income: -167055000 Open source Revenue: 6780000 Open source
20192019-12-31	Free cash flow margin	-917.4%	Revenue: 3001000 Open source Operating Cash Flow: -25636000 Open source Capital Expenditure: 1896000 Open source
20202020-12-31	Free cash flow margin	-3,242.5%	Revenue: 1747000 Open source Operating Cash Flow: -46600000 Open source Capital Expenditure: 10047000 Open source
20212021-12-31	Free cash flow margin	-6,705.2%	Revenue: 1595000 Open source Operating Cash Flow: -91800000 Open source Capital Expenditure: 15148000 Open source
20222022-12-31	Free cash flow margin	-2,407.8%	Revenue: 6780000 Open source Operating Cash Flow: -136700000 Open source Capital Expenditure: 26547000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -136.7M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Operating cash flow	-25636000	Operating Cash Flow: -25636000 Open source
20202020-12-31	Operating cash flow	-46600000	Operating Cash Flow: -46600000 Open source
20212021-12-31	Operating cash flow	-91800000	Operating Cash Flow: -91800000 Open source
20222022-12-31	Operating cash flow	-136700000	Operating Cash Flow: -136700000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -163.2M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Free cash flow	-27532000	Operating Cash Flow: -25636000 Open source Capital Expenditure: 1896000 Open source
20202020-12-31	Free cash flow	-56647000	Operating Cash Flow: -46600000 Open source Capital Expenditure: 10047000 Open source
20212021-12-31	Free cash flow	-106948000	Operating Cash Flow: -91800000 Open source Capital Expenditure: 15148000 Open source
20222022-12-31	Free cash flow	-163247000	Operating Cash Flow: -136700000 Open source Capital Expenditure: 26547000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

67.7% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Liabilities / assets	22.7%	Total Liabilities: 6945000 Open source Total Assets: 30609000 Open source
20202020-12-31	Liabilities / assets	29.7%	Total Liabilities: 33863000 Open source Total Assets: 113828000 Open source
20212021-12-31	Liabilities / assets	147.5%	Total Liabilities: 93033000 Open source Total Assets: 63058000 Open source
20222022-12-31	Liabilities / assets	67.7%	Total Liabilities: 100536000 Open source Total Assets: 148598000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.01× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Current assets / current liabilities	4.62×	Current Assets: 26460000 Open source Current Liabilities: 5725000 Open source
20202020-12-31	Current assets / current liabilities	6.98×	Current Assets: 97099000 Open source Current Liabilities: 13911000 Open source
20212021-12-31	Current assets / current liabilities	0.54×	Current Assets: 33777000 Open source Current Liabilities: 62341000 Open source
20222022-12-31	Current assets / current liabilities	2.01×	Current Assets: 71311000 Open source Current Liabilities: 35560000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−USD 28.65 million Exact value Exact value: -28649000 USD 2019-01-01 – 2019-12-31: -28649000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GreenLight Biosciences Holdings, PBC · 2019-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Net Income: -28649000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28649000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000119312522029838/d151758ds1.htm#5118753 Filing: 000119312522029838 The citation records this snapshot. The page link may show a newer release later.	−USD 25.64 million Exact value Exact value: -25636000 USD 2019-01-01 – 2019-12-31: -25636000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GreenLight Biosciences Holdings, PBC · 2019-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Operating Cash Flow: -25636000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25636000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000119312522029838/d151758ds1.htm#4554946 Filing: 000119312522029838 The citation records this snapshot. The page link may show a newer release later.	USD 1.9 million Exact value Exact value: 1896000 USD 2019-01-01 – 2019-12-31: 1896000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GreenLight Biosciences Holdings, PBC · 2019-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Capital Expenditure: 1896000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1896000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000119312522029838/d151758ds1.htm#4486088 Filing: 000119312522029838 The citation records this snapshot. The page link may show a newer release later.	−USD 27.53 million Calculation and evidence -25636000 − 1896000 USD Exact free cash flow: -27532000 USD 2019-01-01 – 2019-12-31: -25636000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1896000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GreenLight Biosciences Holdings, PBC · 2019-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Free cash flow: -27532000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25636000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000119312522029838/d151758ds1.htm#4554946 Filing: 000119312522029838 Input fundies:CapitalExpenditure: 1896000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000119312522029838/d151758ds1.htm#4486088 Filing: 000119312522029838 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 53.25 million Exact value Exact value: -53251000 USD 2020-01-01 – 2020-12-31: -53251000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GreenLight Biosciences Holdings, PBC · 2020-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Net Income: -53251000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53251000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000119312522251296/d352354ds1.htm#3376176 Filing: 000119312522251296 The citation records this snapshot. The page link may show a newer release later.	−USD 46.6 million Exact value Exact value: -46600000 USD 2020-01-01 – 2020-12-31: -46600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GreenLight Biosciences Holdings, PBC · 2020-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Operating Cash Flow: -46600000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -46600000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000119312522251296/d352354ds1.htm#2650461 Filing: 000119312522251296 The citation records this snapshot. The page link may show a newer release later.	USD 10.05 million Exact value Exact value: 10047000 USD 2020-01-01 – 2020-12-31: 10047000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GreenLight Biosciences Holdings, PBC · 2020-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Capital Expenditure: 10047000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10047000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000119312522251296/d352354ds1.htm#2575861 Filing: 000119312522251296 The citation records this snapshot. The page link may show a newer release later.	−USD 56.65 million Calculation and evidence -46600000 − 10047000 USD Exact free cash flow: -56647000 USD 2020-01-01 – 2020-12-31: -46600000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 10047000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GreenLight Biosciences Holdings, PBC · 2020-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Free cash flow: -56647000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -46600000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000119312522251296/d352354ds1.htm#2650461 Filing: 000119312522251296 Input fundies:CapitalExpenditure: 10047000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000119312522251296/d352354ds1.htm#2575861 Filing: 000119312522251296 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 112.31 million Exact value Exact value: -112310000 USD 2021-01-01 – 2021-12-31: -112310000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GreenLight Biosciences Holdings, PBC · 2021-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Net Income: -112310000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -112310000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#4906384 Filing: 000095017023010351 The citation records this snapshot. The page link may show a newer release later.	−USD 91.8 million Exact value Exact value: -91800000 USD 2021-01-01 – 2021-12-31: -91800000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GreenLight Biosciences Holdings, PBC · 2021-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Operating Cash Flow: -91800000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -91800000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3719733 Filing: 000095017023010351 The citation records this snapshot. The page link may show a newer release later.	USD 15.15 million Exact value Exact value: 15148000 USD 2021-01-01 – 2021-12-31: 15148000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GreenLight Biosciences Holdings, PBC · 2021-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Capital Expenditure: 15148000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15148000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3518751 Filing: 000095017023010351 The citation records this snapshot. The page link may show a newer release later.	−USD 106.95 million Calculation and evidence -91800000 − 15148000 USD Exact free cash flow: -106948000 USD 2021-01-01 – 2021-12-31: -91800000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 15148000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GreenLight Biosciences Holdings, PBC · 2021-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Free cash flow: -106948000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -91800000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3719733 Filing: 000095017023010351 Input fundies:CapitalExpenditure: 15148000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3518751 Filing: 000095017023010351 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 167.06 million Exact value Exact value: -167055000 USD 2022-01-01 – 2022-12-31: -167055000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GreenLight Biosciences Holdings, PBC · 2022-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Net Income: -167055000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -167055000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#4903951 Filing: 000095017023010351 The citation records this snapshot. The page link may show a newer release later.	−USD 136.7 million Exact value Exact value: -136700000 USD 2022-01-01 – 2022-12-31: -136700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GreenLight Biosciences Holdings, PBC · 2022-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Operating Cash Flow: -136700000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -136700000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3718989 Filing: 000095017023010351 The citation records this snapshot. The page link may show a newer release later.	USD 26.55 million Exact value Exact value: 26547000 USD 2022-01-01 – 2022-12-31: 26547000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GreenLight Biosciences Holdings, PBC · 2022-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Capital Expenditure: 26547000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26547000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3516397 Filing: 000095017023010351 The citation records this snapshot. The page link may show a newer release later.	−USD 163.25 million Calculation and evidence -136700000 − 26547000 USD Exact free cash flow: -163247000 USD 2022-01-01 – 2022-12-31: -136700000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 26547000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GreenLight Biosciences Holdings, PBC · 2022-12-31 GreenLight Biosciences Holdings, PBC (edgar:1822691) Free cash flow: -163247000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-12T19:26:52Z Snapshot: bbef97b27f8157858072bf8b145023c658f74e9220b85822d4716874ec85b4ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1822691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -136700000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3718989 Filing: 000095017023010351 Input fundies:CapitalExpenditure: 26547000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1822691/000095017023010351/grna-20221231.htm#3516397 Filing: 000095017023010351 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

58 filings · 692 latest values · 690 originally reported values

Dataset published 2026-11-12. Source filing dates and reporting periods are shown separately.

Identifiers: 0001822691, 1822691, ENVI, GRNA, edgar:1822691

Also known as ENVIRONMENTAL IMPACT ACQUISITION CORP., Environmental Impact Acquisition Corp, GreenLight Biosciences Holdings, PBC

GreenLight Biosciences Holdings, PBC

Holdings and insider activity

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation